Jazz Pharmaceuticals plc - FORM 10-K - EX-10.55 - 2010 AND 2011 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS - March 8, 2011

Attached files

file filename
10-K - FORM 10-K - Jazz Pharmaceuticals plcd10k.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Jazz Pharmaceuticals plcdex231.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Jazz Pharmaceuticals plcdex211.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcdex311.htm
EX-10.54 - JAZZ PHARMACEUTICALS, INC. CASH BONUS PLAN - Jazz Pharmaceuticals plcdex1054.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcdex312.htm
EX-10.53 - SEPARATION AGREEMENT - ROBERT MYERS - Jazz Pharmaceuticals plcdex1053.htm
EX-32.1 - CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Jazz Pharmaceuticals plcdex321.htm

EXHIBIT 10.55

2010 and 2011 Executive Officer Compensation Arrangements

 

Executive Officer

    2010 Base
Salary
Rate(1)		      2010 Target
Bonus as %
of Annual
Base Salary
Rate		      2011 Base
Salary
Rate(2)		      2011 Target
Bonus as %
of Annual
Base Salary
Rate		  

Bruce C. Cozadd

    $ 500,000         60       $ 575,000         65   

Chairman and Chief Executive Officer

            

Russell J. Cox(3)(4)

    $ 260,000         20-35       $ 325,000         40   

Senior Vice President, Sales and

Marketing

            

Michael A. DesJardin

    $ 285,000         40       $ 288,000         40   

Senior Vice President, Product

Development

            

Mark G. Eller, Ph.D.

    $ 280,000         40       $ 288,000         40   

Senior Vice President, Research and

Clinical Development

            

Kathryn E. Falberg

    $ 365,000         40       $ 380,000         40   

Senior Vice President and Chief

Financial Officer

            

Carol A. Gamble

    $ 361,000         40       $ 362,000         40   

Senior Vice President, General

Counsel and Corporate Secretary

            

Robert M. Myers(5)

    $ 448,000         50         —           —     

President

            

Janne L. T. Wissel

    $ 361,000         40       $ 362,000         40   

Senior Vice President, Chief

Regulatory and Compliance Officer

            

Joan E. Colligan

    $ 217,250         10-30       $ 217,250         10-30   

Controller and Principal Accounting

Officer

            

 

(1) Base salary rate beginning March 1, 2010.
(2) Base salary rate beginning March 1, 2011.
(3) Mr. Cox joined the company as Vice President of Marketing on July 21, 2010.
(4) Mr. Cox became Senior Vice President, Sales and Marketing effective January 7, 2011 and his base salary rate, as of that date until March 1, 2011, was increased to $315,000.
(5) Mr. Myers resigned as President effective January 14, 2011. In connection with his resignation, Mr. Myers and the company entered into a separation agreement.

Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports